These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16450916)

  • 1. Quality control in cervical cancer screening: Brazilian experience.
    Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
    Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scan-and-treat methodology using Azure A fast stain as a cost-effective cervical cancer screening alternative to visual inspection with acetic acid.
    Guillaud M; Benedet JL; Follen M; Crain BT; MacAulay C
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S256-9. PubMed ID: 17825881
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving the sensitivity of cervical cytology: what are the issues?
    Myers ER
    Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
    [No Abstract]   [Full Text] [Related]  

  • 5. Colposcopy, cervical screening, and HPV. Preface.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
    [No Abstract]   [Full Text] [Related]  

  • 6. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 7. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
    Bistoletti P
    Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 9. Public expectations, achievable cervical screening sensitivity, and the standard of practice.
    Austin RM
    Cancer; 2003 Feb; 99(1):1-3. PubMed ID: 12589638
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medicine--in real time. Comparing methods of cervical Ca screening.
    Genova NJ
    JAAPA; 2000 Jan; 13(1):55-6, 59-60, 63. PubMed ID: 11503224
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of organized screening in comparison to spontaneous Pap samples in the prevention of invasive cervical cancer].
    Kallio M; Nieminen P; Anttila A; Hakama M
    Duodecim; 2001; 117(14):1442-6. PubMed ID: 12181953
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Liquid-based cytology for cervical screening.
    Blamey S; Jackson T; Robinson J
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):70-1; author reply 71-2. PubMed ID: 16441706
    [No Abstract]   [Full Text] [Related]  

  • 14. Can we change the way we screen?: the ThinPrep Imaging System.
    Dawson AE
    Cancer; 2004 Dec; 102(6):340-4. PubMed ID: 15540250
    [No Abstract]   [Full Text] [Related]  

  • 15. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost-benefit of expanding cervical cancer screening].
    Deng J; Tan H; Yang T; Huang X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):470-5. PubMed ID: 20543471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New ways of cervical cancer screening].
    Teikari M
    Duodecim; 2004; 120(13):1595-6; discussion 1596-7. PubMed ID: 15326967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 20. Pap smear screening for cervical cancer in Singapore: issues to consider.
    Tay EH
    Singapore Med J; 2004 Jun; 45(6):244-6. PubMed ID: 15181515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.